Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pyxis Oncology (PYXS) EPS (Basic) (2024 - 2025)

Pyxis Oncology has reported EPS (Basic) over the past 2 years, most recently at -$0.29 for Q4 2025.

  • Quarterly EPS (Basic) rose 50.85% to -$0.29 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.29 through Dec 2025, changed 0.0% year-over-year, with the annual reading at -$1.28 for FY2025, 3.03% up from the prior year.
  • EPS (Basic) was -$0.29 for Q4 2025 at Pyxis Oncology, up from -$0.35 in the prior quarter.
  • Over five years, EPS (Basic) peaked at -$0.06 in Q1 2024 and troughed at -$0.59 in Q4 2024.